Michael Adelman serves as Executive at Aptevo Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Michael Adelman has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 1, 2019 involved exercising options for 7,318 shares valued at $0.
Michael Adelman currently holds 72,821 shares of Aptevo Therapeutics Inc. (APVO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Adelman has been a net neutral trader of APVO stock. They have purchased $0 and sold $0 worth of shares.
Michael Adelman's most recent insider trade was on Mar 1, 2019, when they sold 7,318 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.57 |
| Discretionary |